What this study is
The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which combines values-elicitation with tailored feedback to patients and providers, improves patient-reported values-concordance of initial treatment decisions compared to usual care.
What's being tested
- Preference Reporting to Improve Management and Experience (PRIME)
Intervention · BEHAVIORAL
PRIME is a decision support tool that uses best-worst scaling to provide a personalized report to providers and patients of their most important treatment priorities
Study details
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Conditions
- Hematologic Malignancies · Lymphoma · Multiple Myeloma · Leukemia · Blood Cancers
- Enrolling
- 500 people
- Starts
- 2024-06-21
- Est. completion
- 2028-09-01
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 60 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
- Written or verbal informed consent obtained to participate in the study and HIPAA authorization for the release of personal health information.
- Subjects are willing and able to comply with study procedures based on the judgment of the investigator.
- Age ≥ 60 years at the time of consent.
- New patient to either the hematologic malignancies clinic or the bone marrow transplant/cellular therapy clinic.
You can't join if
- Dementia, altered mental status, or psychiatric condition that would prohibit the understanding or rendering of informed consent or participation in the intervention.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openLineberger Comphrehensive Cancer Center at University of North Carolina
Chapel Hill, North Carolina, United States
- Madisyn Parker · Contact919-966-3036madisyn_parker@med.unc.edu
- Daniel R Richardson,, MD, MA, MSc · Principal investigator
Recruiting
Study team
Sponsor
UNC Lineberger Comprehensive Cancer Center
Study ID LCCC2305
Principal investigator
Daniel R Richardson, MD, MA, MSc
UNC Lineberger Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.